Concentrix CORP (CNXC) — SEC Filings

Q: What are the key financial highlights for Concentrix CORP?

Key financial highlights for Concentrix CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Concentrix CORP?

Key executives at Concentrix CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Concentrix CORP stock?

Risk factors for Concentrix CORP (CNXC) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Concentrix CORP?

Forward-looking statements and predictions from Concentrix CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Concentrix CORP. Recent 10-Q filing on Apr 3, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Concentrix CORP on SEC EDGAR

Overview

Concentrix CORP (CNXC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Apr 3, 2026: Concentrix Corp (CNXC) filed a Quarterly Report (10-Q) with the SEC on April 3, 2026. Filing Date: 2026-04-03. Period of Report: 2026-02-28. Document Type: 10-Q. SEC Accession No.: 0001803599-26-000122. Company CIK: 0001803599.

Sentiment Summary

Across 48 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 45 neutral. The dominant filing sentiment for Concentrix CORP is neutral.

Filing Type Overview

Concentrix CORP (CNXC) has filed 1 3, 7 4, 7 10-Q, 20 8-K, 3 DEF 14A, 2 10-K, 6 SC 13G/A, 1 DEFA14A, 1 SC 13D/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (48)

Concentrix Corp Files Quarterly Report on Form 10-Q — 10-Q · Apr 3, 2026 Risk: low
Concentrix Corp (CNXC) filed a Quarterly Report (10-Q) with the SEC on April 3, 2026. Filing Date: 2026-04-03. Period of Report: 2026-02-28. Document Type: 10-Q
4 Filing — 4 · Mar 27, 2026
4 Filing — 4 · Mar 27, 2026
4 Filing — 4 · Mar 27, 2026
Concentrix Corp. Files Form 4 on Ownership Changes — 4 · Mar 27, 2026 Risk: low
On March 27, 2026, Concentrix Corp. filed a Form 4, reporting changes in beneficial ownership of securities. The filing pertains to the period ending March 25,
Concentrix Corp: Insider Ownership Change Reported — 4 · Mar 27, 2026 Risk: low
On March 25, 2026, Kathryn V. Marinello, a reporting person for Concentrix Corporation, reported a change in beneficial ownership of securities. The filing deta
4 Filing — 4 · Mar 27, 2026
4 Filing — 4 · Mar 27, 2026
Concentrix Corp. Files 8-K on Officer Changes and Compensation — 8-K · Mar 27, 2026 Risk: medium
On March 25, 2026, Concentrix Corp. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also inc
3 Filing — 3 · Mar 27, 2026
Concentrix Files Q1 2026 Results, Financial Condition Update — 8-K · Mar 24, 2026
Concentrix Corp filed an 8-K on March 24, 2026, announcing its results of operations and financial condition, likely for the first quarter of 2026, as indicated
Concentrix Net Income Soars 430% on Strong Revenue Growth — 10-Q · Oct 3, 2025 Risk: medium
Concentrix Corp (CNXC) reported a robust financial performance for the three and nine months ended August 31, 2025. Revenue increased by 4.0% to $2.48 billion f
Concentrix Corp Files 8-K on Financials — 8-K · Sep 25, 2025 Risk: low
Concentrix Corporation filed an 8-K on September 25, 2025, to report on its Results of Operations and Financial Condition, as well as Financial Statements and E
Concentrix Swings to Loss Amid Revenue Dip — 10-Q · Jul 3, 2025 Risk: high
Concentrix Corp reported a net loss of $10.7 million for the three months ended May 31, 2025, a significant decline from a net income of $77.8 million in the pr
Concentrix Corp Files 8-K on Financials — 8-K · Jun 26, 2025 Risk: low
Concentrix Corporation filed an 8-K on June 26, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibi
Concentrix Corp Announces Executive and Director Changes — 8-K · Jun 5, 2025 Risk: medium
Concentrix Corporation announced on June 3, 2025, changes in its executive and director compensation arrangements. The filing details the departure of certain o
Concentrix Corp Enters Material Definitive Agreement — 8-K · Apr 11, 2025 Risk: medium
On April 11, 2025, Concentrix Corporation entered into a material definitive agreement, likely related to a financial obligation. The filing also indicates the
Concentrix Corp Files Q1 2025 10-Q — 10-Q · Apr 4, 2025 Risk: low
Concentrix Corp filed its 10-Q for the period ending February 28, 2025. The filing details financial performance and operational updates for the quarter. Key fi
Concentrix Files 8-K on Shareholder Votes and Financials — 8-K · Mar 31, 2025 Risk: low
Concentrix Corporation filed an 8-K on March 25, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing does no
Concentrix Corp Files 8-K on Financials — 8-K · Mar 26, 2025 Risk: low
On March 26, 2025, Concentrix Corporation filed an 8-K report detailing its financial condition and results of operations. The filing includes financial stateme
Concentrix Corp Files DEF 14A for FY24 Executive Compensation — DEF 14A · Feb 13, 2025 Risk: low
Concentrix Corp filed its DEF 14A on February 13, 2025, for the fiscal year ending November 30, 2024. The filing details executive compensation and other corpor
Concentrix Corp Files 2024 Annual Report — 10-K · Jan 28, 2025 Risk: medium
Concentrix Corp filed its 10-K for the fiscal year ending November 30, 2024, reporting its financial performance and business operations. The company, incorpora
Concentrix Corp Enters Material Definitive Agreement — 8-K · Jan 21, 2025 Risk: medium
On January 14, 2025, Concentrix Corporation entered into a material definitive agreement, which also created a direct financial obligation for the registrant. T
Concentrix Corp Files 8-K on Financials — 8-K · Jan 15, 2025 Risk: low
Concentrix Corporation filed an 8-K on January 15, 2025, reporting on its results of operations and financial condition. The filing includes financial statement
Concentrix Corp Files 8-K: Bylaws Amended, Financials Included — 8-K · Jan 10, 2025 Risk: low
Concentrix Corporation filed an 8-K on January 10, 2025, reporting events as of January 9, 2025. The filing indicates amendments to articles of incorporation or
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
Concentrix Changes Auditors to Ernst & Young — 8-K · Oct 30, 2024 Risk: low
On October 25, 2024, Concentrix Corporation filed an 8-K report to disclose changes in its certifying accountant. The company's Audit Committee of the Board of
Concentrix Corp Files 8-K on Officer Changes & Shareholder Votes — 8-K · Oct 29, 2024 Risk: low
Concentrix Corporation filed an 8-K on October 29, 2024, reporting on the departure of directors or certain officers, election of directors, appointment of cert
Concentrix Corp Files Q3 2024 10-Q — 10-Q · Oct 4, 2024 Risk: low
Concentrix Corp filed its 10-Q for the period ending August 31, 2024. The filing covers the third quarter of fiscal year 2024. Key financial data and operationa
Concentrix Corp Files 8-K on Operations and Financials — 8-K · Sep 25, 2024 Risk: low
On September 25, 2024, Concentrix Corporation filed an 8-K report to disclose information regarding its results of operations and financial condition, as well a
Concentrix Corp Files Additional Proxy Materials — DEFA14A · Sep 24, 2024 Risk: low
Concentrix Corporation filed a Definitive Additional Materials proxy statement on September 24, 2024. This filing is related to the company's proxy materials an
Concentrix Corp DEF 14A: Executive Compensation Details — DEF 14A · Sep 17, 2024 Risk: medium
Concentrix Corp filed a DEF 14A on September 17, 2024, detailing executive compensation and other corporate governance matters for the fiscal year ending Novemb
Impactive Capital Amends Concentrix Stake — SC 13D/A · Aug 7, 2024 Risk: medium
Impactive Capital LP, through its filing on August 7, 2024, has amended its Schedule 13D regarding Concentrix Corporation. The filing indicates a change in bene
Concentrix Corp. Files Q2 2024 10-Q — 10-Q · Jul 5, 2024 Risk: low
Concentrix Corp. filed its 10-Q for the period ending May 31, 2024. The filing covers the second quarter of fiscal year 2024. Key financial data and operational
Concentrix Corp Files 8-K on Financials — 8-K · Jun 26, 2024 Risk: low
On June 26, 2024, Concentrix Corporation filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations. It also
Concentrix Corp Enters Material Definitive Agreement — 8-K · Apr 26, 2024 Risk: medium
On April 25, 2024, Concentrix Corporation entered into a material definitive agreement related to a financial obligation. The filing does not disclose specific
Concentrix Corp Files 10-Q for Period Ending February 29, 2024 — 10-Q · Apr 5, 2024 Risk: low
Concentrix Corp (CNXC) filed a Quarterly Report (10-Q) with the SEC on April 5, 2024. Filing is a 10-Q for Concentrix Corp for the period ending February 29, 20
Concentrix Corp Files 8-K on Financials — 8-K · Mar 26, 2024 Risk: low
On March 26, 2024, Concentrix Corporation filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhib
Concentrix Files 8-K for Other Events and Exhibits — 8-K · Mar 22, 2024 Risk: low
Concentrix Corporation filed an 8-K on March 22, 2024, to report other events and financial statements. The filing does not contain specific details about new m
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
Capital International Investors Trims Concentrix Stake to 5.0% — SC 13G/A · Feb 9, 2024 Risk: low
Capital International Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing their ownership in Concentrix Corp. A
FMR LLC & Abigail Johnson Maintain 11.122% Stake in Concentrix — SC 13G/A · Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership in Concentrix Corp (CNXC) through an SC 13G/A filing on February
Concentrix Corp Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Feb 8, 2024 Risk: low
Concentrix Corp (CNXC) filed a Proxy Statement (DEF 14A) with the SEC on February 8, 2024. Filing is a Definitive Proxy Statement (DEF 14A) for Concentrix Corp.
Synnex Holds 3.5M Concentrix Shares, Maintains Sole Voting Power — SC 13G/A · Feb 6, 2024
Synnex Technology International Corporation, a Taiwanese company, filed an amendment to its SC 13G, indicating it beneficially owns 3,545,840 shares of Concentr
BlackRock Amends Concentrix Stake, Maintains Passive Position — SC 13G/A · Jan 29, 2024
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, disclosing its ownership of Concentrix Corp (CNXC) common stock as of December 31, 2023. This amen
Concentrix Corp Files 2023 Annual Report on Form 10-K — 10-K · Jan 29, 2024 Risk:
Concentrix Corp (CNXC) filed a Annual Report (10-K) with the SEC on January 29, 2024. Concentrix Corp filed its 10-K for the fiscal year ending November 30, 202
Concentrix Files 8-K on Financial Condition & Results — 8-K · Jan 24, 2024
Concentrix Corporation filed an 8-K on January 24, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits
Concentrix 8-K: No New Officer Changes or Comp Arrangements — 8-K · Jan 5, 2024
Concentrix Corporation filed an 8-K on January 5, 2024, reporting no new material events regarding departures or appointments of officers or directors, nor any

Risk Profile

Risk Assessment: Of CNXC's 34 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 24 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

Kathryn V. Marinello
Lauren Taylor Wolfe
Christian Asmar
Eleazer Klein, Esq.
Adriana Schwartz, Esq.
Abigail P. Johnson

Industry Context

Concentrix Corp operates in the business services sector, providing a range of customer engagement and business process outsourcing solutions.

Top Tags

financial-reporting (8) · corporate-governance (7) · 8-K (6) · 10-Q (5) · amendment (5) · Concentrix Corp (4) · institutional-ownership (4) · executive-compensation (3) · quarterly-report (3) · operations (3)

Key Numbers

Filing Date: 2026-04-03 — SEC Filing
Period of Report: 2026-02-28 — SEC Filing
Document Type: 10-Q — SEC Filing
SEC Accession No.: 0001803599-26-000122 — SEC Filing
SEC Accession Number: 0001803599-26-000092 — Unique identifier for this specific 8-K filing
Revenue: $2.48B — Increased 4.0% for the three months ended August 31, 2025, from $2.39B in prior year.
Net Income: $88.11M — Increased 430% for the three months ended August 31, 2025, from $16.63M in prior year.
Diluted EPS: $1.34 — Increased from $0.25 for the three months ended August 31, 2025.
Cash and Cash Equivalents: $350.26M — Increased from $240.57M at November 30, 2024.
Long-term Debt, net: $4.79B — Increased from $4.73B at November 30, 2024.
Common Shares Outstanding: 62,257,439 — As of September 30, 2025.
Repurchase of Common Stock: $112.77M — For the nine months ended August 31, 2025.
Net Loss: $10.7M — Concentrix swung from a $77.8M net income in Q2 2024 to a $10.7M net loss in Q2 2025.
Accumulated Other Comprehensive Income Change: -$10.0M — AOCI decreased by $10.0M in Q2 2025, compared to a $1.0M increase in Q2 2024.
Fiscal Year End: 1130 — Indicates the company's annual financial reporting cycle.

Forward-Looking Statements

{"claim":"Capital International Investors will continue to monitor and potentially adjust its stake in Concentrix Corp. based on market conditions and company performance.","entity":"Capital International Investors","targetDate":"Next 6-12 months","confidence":"medium"}
{"claim":"FMR LLC will maintain a significant ownership stake in Concentrix Corp, indicating continued long-term investment.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}
{"claim":"Concentrix will likely hold its annual shareholder meeting around the conformed period of report date.","entity":"Concentrix Corp","targetDate":"20240321","confidence":"high"}

Related Companies

TTEC · TEL

Frequently Asked Questions

What are the latest SEC filings for Concentrix CORP (CNXC)?

Concentrix CORP has 48 recent SEC filings from Jan 2024 to Apr 2026, including 20 8-K, 7 4, 7 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of CNXC filings?

Across 48 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 45 neutral. The dominant sentiment is neutral.

Where can I find Concentrix CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Concentrix CORP (CNXC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Concentrix CORP?

Key financial highlights from Concentrix CORP's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for CNXC?

The investment thesis for CNXC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Concentrix CORP?

Key executives identified across Concentrix CORP's filings include Kathryn V. Marinello, Lauren Taylor Wolfe, Christian Asmar, Eleazer Klein, Esq., Adriana Schwartz, Esq. and 1 others.

What are the main risk factors for Concentrix CORP stock?

Of CNXC's 34 assessed filings, 1 were flagged high-risk, 9 medium-risk, and 24 low-risk.

What are recent predictions and forward guidance from Concentrix CORP?

Recent forward-looking statements from Concentrix CORP include guidance on {"claim":"Capital International Investors will continue to monitor and potentially adjust its stake in Concentrix Corp. and 2 other predictions.